Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Pegfilgrastim Biosimilar (Cipla Australia Pty Ltd.), FILPEGLA |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date AU (19 Aug 2022), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Febrile Neutropenia | AU | 19 Aug 2022 |